Erick Lucera Insider Trades & Stock Holdings

Chief Financial Officer · Dyne Therapeutics, Inc. · Latest filing Jun 25, 2026

Erick Lucera, Chief Financial Officer at Dyne Therapeutics, Inc. has 1 Form 4 trade on file since Jun 25, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($48.11K), net -$48.11K. Latest filing: disposed of 2.36K shares of $DYN on Jun 25, 2026 at $20.37.

Trades on file

1

Open-market bought

$0

Open-market sold

$48.11K

Net open-market

-$48.11K

Latest filing

Jun 25, 2026

All insider trades by Erick Lucera

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 25, 2026	$DYN	Sell (Open-market sale)	2.36K	$20.37	$48.11K			+11.9%	+24.4%		Chief Financial Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Erick Lucera traded

• $DYN

Frequently asked questions

Has Erick Lucera been buying or selling stock?

Erick Lucera has 0 open-market purchases and 1 open-market sale on file, net -$48.11K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Erick Lucera's latest insider trade?

disposed of 2.36K shares of $DYN on Jun 25, 2026 at $20.37.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.